Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.6K Buy
830
+87
+12% +$8.19K 0.01% 245
2026
Q1
$87.8K Buy
743
+243
+49% +$30K 0.01% 178
2025
Q4
$62.9K Sell
500
-606
-55% -$79K 0.01% 186
2025
Q3
$162K Buy
1,106
+146
+15% +$22.1K 0.03% 204
2025
Q2
$150K Sell
960
-367
-28% -$58.2K 0.03% 205
2025
Q1
$218K Hold
1,327
0.05% 166
2024
Q4
$216K Buy
1,327
+474
+56% +$84.8K 0.05% 161
2024
Q3
$167K Buy
853
+20
+2% +$3.69K 0.04% 191
2024
Q2
$144K Sell
833
-3
-0.4% -$499 0.03% 196
2024
Q1
$141K Sell
836
-16
-2% -$3K 0.04% 180
2023
Q4
$168K Sell
852
-1,280
-60% -$227K 0.05% 148
2023
Q3
$371K Buy
+2,132
New +$387K 0.15% 67

Other funds holding ZTS

Arlington Trust's ZTS Position: Q2 2026 in Review

Arlington Trust increased its Zoetis (ZTS) stake by 12% in Q2 2026, buying an estimated $8.19K and bringing the position to 830 shares worth $59.6K. The position accounts for 0.01% of the portfolio, ranked #245.

Arlington Trust first reported a position in ZTS in Q3 2023 and has held it in 12 quarters since. The position peaked at $371K in Q3 2023. 271 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Arlington Trust held 830 shares of Zoetis worth $59.6K as of Q2 2026.
  • Arlington Trust bought 87 Zoetis shares in Q2 2026, an estimated $8.19K.
  • Zoetis made up 0.01% of Arlington Trust's portfolio in Q2 2026, its #245 holding.
  • Arlington Trust first reported a position in Zoetis in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's Zoetis position peaked at $371K in Q3 2023.
  • 271 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.